Ology Bioservices, Inc.

Therapure Biopharma Inc

Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. 

U.S. Department of Defense

U.S. International Development Finance Corp

Mubadala

Magnetic Ventures

ARCH Venture Partners

Google Ventures

Lux Capital

New Enterprise Associates

Resilience

When your need for larger-scale vaccine production outgrows your cell stacks or flasks, there is a clear and easy path to scale up and maximize your yields. 

Learn how our team of process development experts and proprietary Vero and Quail cell lines can support the development of your vaccine with Path-to-PAD (Process and Analytical Development) in our latest blog post: https://hubs.ly/Q02l0J9Q0 

#Development #Vaccine #CellLine

On #RareDiseaseDay, Resilience joins the rare disease community in advocating for people and families living with rare diseases. 
 
We are honored to partner with @BridgeBio, as together we remain dedicated to accelerating the development of innovative therapies for families living with Canavan disease and congenital adrenal hyperplasia.
 
Learn more:https://hubs.ly/Q02m7gP00

Drug Development & Delivery recently interviewed Resilience Chief Commercial Officer Syed T. Husain about how Resilience was built to revolutionize the CDMO space with a refocus on the foundations of biomanufacturing, a reprioritization on manufacturing technology development, and a redefinition of partnership. Read the full article: https://hubs.ly/Q02kTsdy0 

DCAT Week 2024 is just around the corner – make the most of your time in New York City by securing a meeting with Resilience. Request a meeting: https://hubs.ly/Q02m5z6x0 

#DCATWeek


The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource critical stages of their biomanufacturing processes.

Our recent whitepaper, "The Stage-Gate Model: A Value-Driven Approach to Accelerate Biomanufacturing," highlights how to perform critical activities leveraging process and analytical development resources from early-stage clinical to commercialization: https://hubs.ly/Q02hyVMH0

#biomanufacturing #techtransfer #processdevelopment #analyticaldevelopment #resilience

Sentry is a biomanufacturing company providing similar services in vaccine and analytical development for the pharmaceutical sector.

Sentry

Pacific BioLabs is a company specializing in biopharmaceutical manufacturing and technology, potentially overlapping with Resilience's offerings.

Pacific BioLabs

Camargo is a company involved in advanced biopharmaceutical manufacturing, aligning with Resilience's focus on changing the way medicine is produced.

Camargo

Resilience is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. They are focused on creating processes and platforms to enable scientists to make novel therapies quickly, safely, and at scale.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 5, 2024 1:47 AM	7c302e89
public peers	general
news daily refresh	general	Sep 1, 2024 6:20 PM	280304b7
news processing daily refresh	general	Sep 2, 2024 1:49 PM	e620d464
news impact assignment daily	general	Sep 2, 2024 11:32 PM	c14983dd
news processing basic	general	Mar 5, 2024 1:47 AM	b3c2ce77
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 5, 2024 1:47 AM	2ac078eb
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 5, 2024 1:47 AM	7a4a62b5
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:RESILIENCE

Resilience